Federation Des Caisses Desjardins Du Quebec Ligand Pharmaceuticals Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Aug 30, 2024	SELL	$86.25 - $120.16 $3,018 - $4,205	-35 Closed	0 $0
Q2 2019 Aug 30, 2024	SELL	$107.38 - $129.34 $148,721 - $179,135	-1,385 Reduced 97.54%	35 $4 Million
Q1 2019 Aug 30, 2024	SELL	$105.93 - $142.47 $48,304 - $64,966	-456 Reduced 24.31%	1,420 $178 Million
Q4 2018 Aug 30, 2024	BUY	$128.36 - $272.13 $240,803 - $510,515	1,876 New	1,876 $255 Million
Q3 2018 Aug 30, 2024	SELL	$211.18 - $274.49 $8,869 - $11,528	-42 Reduced 2.17%	1,892 $519 Million
Q2 2018 Aug 30, 2024	BUY	$150.77 - $207.98 $291,589 - $402,233	1,934 New	1,934 $401 Million
Q1 2018 Aug 30, 2024	SELL	$138.63 - $182.62 $34,380 - $45,289	-248 Closed	0 $0
Q4 2017 Aug 30, 2024	SELL	$128.36 - $147.04 $93,317 - $106,898	-727 Reduced 74.56%	248 $34 Million
Q3 2017 Aug 30, 2024	SELL	$120.91 - $137.94 $30,832 - $35,174	-255 Reduced 20.73%	975 $133 Million
Q2 2017 Aug 30, 2024	BUY	N/A	1,230	1,230 $149 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account